CTIX

[CTIX @Kevetrin]

Brilacidin: New Class of #Anitbiotics HDP Mimics to Enter Phase 3 Clinical Trial https://t.co/1HiReW2bjS #AntibioticResistance $CTIX

[CTIX @Kevetrin]

$CTIX requests meeting with FDA for Phase 2 #ovariancancer Study. FDA Orphan Drug Designation for Kevetrin granted. https://t.co/aWP1WT2Gud

[CTIX @Kevetrin]

We've collected enough Pharmacokinetic data for planning Kevetrin Phase 2 trials $CTIX #ovariancancer #P53 #cancer https://t.co/aWP1WT2Gud

[CTIX @Kevetrin]

Results support the concept that Kevetrin activates #p53 by inducing p21 gene expression https://t.co/CvL7mIMkbj #Cancer #ovariancancer

[CTIX @Kevetrin]

Clinical Trial of Anti-Cancer Agent Kevetrin Meeting Its Goals, Approaching End of Trial. https://t.co/AIspqLJ5Mw $CTIX #P53

[Bruce Odell @brucethepotter]

That's Right $CTIX can help people like p53 helps elephants! @LindseyTanner @KarinCAtrades @Kevetrin @cvpayne http://t.co/oG3kvKRns1

[CTIX @Kevetrin]

Cellceutix Announces Filing of its Annual Report http://t.co/aay41AMZWt $CTIX #OvarianCancerAwarenessMonth #ovariancancer #antibiotic

[CTIX @Kevetrin]

Phase 1 Kevetrin trial provided compelling data with respect to #ovariancancer #OvarianCancerAwarenessMonth http://t.co/8VSymE2yek #CTIX

[CTIX @Kevetrin]

Cellceutix Plans for Kevetrin Phase 2 Clinical Trial in #Ovariancancer #OvarianCancerAwarenessMonth http://t.co/8VSymE2yek #cancer $CTIX

[CTIX @Kevetrin]

Brilacidin #Oralmucositis Phase2 Clinical Trial 5 sites recruiting #Mucositis #Cancer https://t.co/O4hCU7hXDi & http://t.co/5RdM4cAJR0 $CTIX

[CTIX @Kevetrin]

Cellceutix Prurisol #Psoriasis Phase 2 Clinical Trial recruiting. https://t.co/Gp8aTSo1EC http://t.co/KuUofbBClg $CTIX

[CTIX @Kevetrin]

Cellceutix Conducts Research on #Retinoblastoma #cancer http://t.co/8YLblRVQlM $CTIX

[CTIX @Kevetrin]

Cellceutix Requesting Meeting with FDA on Kevetrin for Pediatric #retinoblastoma #Cancer $CTIX http://t.co/DBOPebVFSP

[CTIX @Kevetrin]

These results support the concept that Kevetrin activates p53 by inducing p21 gene expression. #P53 #ovariancancer http://t.co/spmhcpOwTI

[CTIX @Kevetrin]

$CTIX Clinical Trial of Anti-Cancer Agent Kevetrin Meeting Its Goals, Approaching End of Trial. #ovariancancer #p53 http://t.co/j0PVFEERaw

[CTIX @Kevetrin]

Kevetrin, 4 of 9 patients with advanced #OvarianCancer documented to have stable disease for 3 to 6 months. $CTIX http://t.co/rdZSzupu5E

[CTIX @Kevetrin]

$CTIX 4 clinical trials for three drugs for 4 indications. Share price only $3.50 1 Phase3, 2 P2, 1 P1. #Cancer #MRSA #psoriasis #mucositis

[CTIX @Kevetrin]

$CTIX now Phase 3 Clinical Trial #antibiotics #MRSA FDA approved, 2 P2 #psoriasis & #mucositis, and 1 P1 #Cancer https://t.co/Dlsf09MWyD

[CTIX @Kevetrin]

Cellceutix to Start Brilacidin Phase 3 Program in ABSSSI $CTIX #MRSA #antibioticresistance #antibiotics http://t.co/LEFNl2s0bY

[CTIX @Kevetrin]

$CTIX FDA Orphan Drug Designation for #ovariancancer (connecting the dots) http://t.co/EClMVi3lWS